This image provided by Eli Lilly shows the company's new Alzheimer’s drug Kisunla. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday, July 2, 2024 for mild or early cases of dementia caused by Alzheimer’s.The approval for donanemab, to be sold under the brand name Kisunla, followed the recommendations of the agency’s outside experts, who unanimously backed its use in patients with early Alzheimer’s disease, saying the benefits of the drug outweighed its risks.
Like Eisai 4523.T and Biogen’s BIIB.O rival drug Leqembi, which was approved a year ago, donanemab is designed to clear an Alzheimer’s-related protein called beta amyloid from the brain.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lilly Wins FDA Approval for New Drug to Slow Alzheimer’s DiseaseEli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the mind-robbing disease that afflicts 6 million Americans.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
FDA approves a second Alzheimer's drug that can modestly slow diseaseWASHINGTON (AP) —
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
FDA approves a second Alzheimer's drug that can modestly slow diseaseU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
Source: CTVNews - 🏆 1. / 99 Read more »
U.S. FDA approves second Alzheimer’s drug that can modestly slow diseaseThe drug could provide a new option for patients in the early stages of the incurable, memory-destroying ailment
Source: globeandmail - 🏆 5. / 92 Read more »
FDA approves Eli Lilly's Alzheimer's drug KisunlaEli Lilly's (LLY) Alzheimer's treatment drug Kisunla has gained approval by the US Food and Drug Administration. Yahoo Finance Health Reporter Anjalee...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »